| 000 | 01757 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518045653.0 | ||
| 264 | 0 | _c20200619 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1941-2703 | ||
| 024 | 7 |
_a10.1089/jamp.2018.1520 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAllan, Richard | |
| 245 | 0 | 0 |
_aA Dose-Response Study to Examine the Methodology for Demonstrating the Local Therapeutic Equivalence of the Fluticasone Propionate Component of an Orally Inhaled Combination Therapy of Fluticasone Propionate/Salmeterol Dry Powder. _h[electronic resource] |
| 260 |
_bJournal of aerosol medicine and pulmonary drug delivery _c12 2019 |
||
| 300 |
_a364-373 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluticasone-Salmeterol Drug Combination _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHaughie, Scott | |
| 700 | 1 | _aKerwin, Edward | |
| 700 | 1 | _aWard, Jon | |
| 773 | 0 |
_tJournal of aerosol medicine and pulmonary drug delivery _gvol. 32 _gno. 6 _gp. 364-373 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/jamp.2018.1520 _zAvailable from publisher's website |
| 999 |
_c29856087 _d29856087 |
||